Control of drug concentration-time profiles in vivo by zero-order transdermal delivery systems
- 31 December 1987
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 6 (1) , 99-106
- https://doi.org/10.1016/0168-3659(87)90067-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Preformulation of an Ara-A transdermal delivery system: Membrane fabrication and characterizationJournal of Controlled Release, 1987
- Physical model evaluation of topical prodrug delivery—simultaneous transport and bioconversion of vidarabine-5′-valerate III: Permeability differences of vidarabine and n-pentanol in components of hairless mouse skinJournal of Pharmaceutical Sciences, 1980
- Physical Model Evaluation of Topical Prodrug Delivery—simultaneous Transport and Biocnversion of Vidarabine-5′-valerate II: Parameter DeterminationsJournal of Pharmaceutical Sciences, 1979
- Physical Model Evaluation of Topical Prodrug Delivery—simultaneous Transport and Bioconversion of vidarabine-5′-valerate I: Physical Model DevelopmentJournal of Pharmaceutical Sciences, 1979
- Treatment of Herpes Simplex Virus Types 1 and 2 Encephalitis in Mice with 9-β- d -ArabinofuranosyladenineAntimicrobial Agents and Chemotherapy, 1973
- Permselectivity of solutes in homogeneous water-swollen polymer membranesJournal of Macromolecular Science, Part B, 1971
- The Chemotherapy of Herpes Iritis With Adenine Arabinoside and CytarabineArchives of Ophthalmology (1950), 1970
- The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A)Chemotherapy, 1968